Information Technology major Infosys Ltd and consulting and outsourcing services provider Accenture Plc said on Wednesday they would cover Covid-19 vaccination costs for their employees in India, as the country expands its massive vaccination drive. India’s vaccination campaign ramped up on Monday, with people above the age of 60, and individuals 45 or older suffering from certain medical conditions, now eligible for shots. Vaccines administered at government health facilities will still be free, while private facilities cannot charge more than Rs 250 ($3.43) per dose, the government has said. “Infosys is looking at partnering with health care providers to vaccinate employees and their immediate families as eligible,” chief operating officer Pravin Rao said in an emailed statement. For Accenture, costs for employees and dependents who are eligible and choose to receive the vaccination will be covered, the company said. So far, the government has procured the two Covid-19 vaccines approved in India – AstraZeneca ‘s shot being developed by the Serum Institute, and local player Bharat Biotech ‘s Covaxin – at fixed prices and distributed them free of cost. Several Indian companies, including autos-to-technology conglomerate Mahindra Group and consumer goods giant ITC Ltd, had already started considering buying Covid-19 vaccines… Read full this story
- Why Can’t Trump Consider Russia's Sputnik V COVID Vaccine as US Remains Worst-Hit Country?
- Covid Speed Read: Nandan Nilekani recommends Aadhaar-like model for Covid vaccination; SC slams Centre for interest during moratorium
- Race for Covid vaccine: Are Indian vaccine makers ready to supply to the world?
- Lack of staff, funds and tools: health officials worry the US isn’t ready for Covid vaccines
- As Covid-19 cases cross 24 million globally, a look at 5 much-awaited vaccines
- ‘India at forefront of research for Covid-19 vaccine’, says PM Modi at US-India summit
- India’s COVID-19 fatality rate among world’s lowest at 1.76%
- China administers experimental COVID-19 vaccines to high-risk groups since a month, says official
- Covid Speed Read: FinMin releases GST compensation roadmap; US FDA considers authorising vaccine before Phase III trials
- Covid Speed Read: SOPs for examinations released; 72% Indians do not want to risk returning to workplace
- Prepare for COVID-19 vaccines by the end of OCTOBER: CDC instructs states to be ready to start giving out one of two potential shots DAYS before the election - but experts claim it's a 'political stunt'
- Health officials worry nation not ready for COVID-19 vaccine
Infosys, Accenture to cover COVID vaccination costs for employees in India have 382 words, post on www.gadgetsnow.com at March 3, 2021. This is cached page on CHUTEU. If you want remove this page, please contact us.